China CAS:979-02-2 Manufacturer

We've got our personal profits workforce, design and style team, technical group, QC crew and package workforce. We have now strict good quality handle procedures for each process. Also, all of our workers are experienced in printing subject for CAS:979-02-2, High quality, timely service and Aggressive rate, all earn us a excellent fame in xxx field despite the international intense competition.
CAS:979-02-2, now we have 8 years experience of production and 5 years experience in trading with the customers all over the world. our clients mainly distributed in the North America, Africa and Eastern Europe. we can supply high quality items with the very competitive price.

Hot Products

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • 16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA) is the dehydration product of Pregnenolone Acetate..

    CAS:979-02-2

  • Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30
    Indications:Gastric ulcer
  • Compound Mifepristone Tablets

    Compound Mifepristone Tablets

    Compound Mifepristone Tablets Specifications:Mifepristone 30mg Anorethidrane 5mg*2
    Indications:Abortion
  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • 3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:302-97-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept